Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2496 | IMMX Immix Biopharma, Inc. - Common Stock | 13.34 USD | -2.34% | +17.12% | +54.58% | +520.47% | 954.33 M USD | ||
| 2500 | ARDX Ardelyx, Inc. - Common Stock | 3.80 USD | -2.31% | -6.63% | -25.93% | -38.11% | 946.91 M USD | ||
| 2515 | CLYM Climb Bio, Inc. - Common Stock | 16.27 USD | -5.84% | -5.41% | +24.20% | +197.44% | 934.49 M USD | ||
| 2525 | OLMA Olema Pharmaceuticals, Inc. - Common Stock | 10.55 USD | -1.31% | -2.76% | -11.94% | +28.82% | 923.10 M USD | ||
| 2533 | IVA Inventiva S.A. - American Depository Shares | 4.64 USD | -0.85% | -1.28% | +4.50% | -2.73% | 896.62 M USD | ||
| 2544 | TBPH Theravance Biopharma, Inc. - Ordinary Shares | 17.01 USD | 0.00% | +0.29% | +0.83% | +18.54% | 883.14 M USD | ||
| 2582 | DBVT DBV Technologies S.A. - American Depositary Shares | 14.22 USD | -2.27% | -3.00% | +3.42% | +44.95% | 842.00 M USD | ||
| 2583 | RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 45.70 USD | -0.41% | +7.55% | +22.52% | +51.68% | 853.67 M USD | ||
| 2614 | ACHV Achieve Life Sciences, Inc. - Common Shares | 7.87 USD | -1.50% | +6.21% | +27.35% | +149.05% | 809.84 M USD | ||
| 2616 | AURA Aura Biosciences, Inc. - Common Stock | 7.80 USD | 0.00% | +2.63% | +9.86% | +19.27% | 808.90 M USD | ||
| 2617 | FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 14.49 USD | -8.46% | -2.49% | +41.78% | +28.23% | 800.49 M USD | ||
| 2624 | PHAR Pharming Group N.V. - ADS, each representing 10 | 11.45 USD | -2.72% | -4.58% | -11.58% | -19.71% | 803.42 M USD | ||
| 2633 | NVCT Nuvectis Pharma, Inc. - Common Stock | 24.20 USD | +2.72% | +26.70% | +24.94% | +251.23% | 788.47 M USD | ||
| 2637 | STTK Shattuck Labs, Inc. - Common Stock | 7.83 USD | +3.98% | +6.39% | +6.24% | +741.94% | 785.84 M USD | ||
| 2661 | GYRE Gyre Therapeutics, Inc. - Common Stock | 6.72 USD | -2.75% | -1.03% | +11.81% | -18.64% | 749.35 M USD | ||
| 2662 | NGNE Neurogene Inc. - Common Stock | 39.81 USD | +3.05% | +7.92% | +13.74% | +35.32% | 796.65 M USD | ||
| 2687 | BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.26 USD | +1.98% | +1.98% | +2.89% | +2.21% | 742.41 M USD | ||
| 2688 | CTMX CytomX Therapeutics, Inc. - Common Stock | 3.33 USD | +1.52% | -2.92% | +2.46% | +56.34% | 725.60 M USD | ||
| 2691 | PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 8.91 USD | +0.45% | -6.11% | -23.19% | -25.44% | 720.83 M USD | ||
| 2699 | MNPR Monopar Therapeutics Inc. - Common Stock | 109.30 USD | +1.47% | -6.28% | -0.90% | +100.11% | 733.64 M USD |
Nachrichten Biotechnology Stocks
Alto Neuroscience Aktie erreicht Allzeithoch bei 35,42 USD
Deutsche Bank stuft Argenx Aktie wegen Bewertung auf ’Hold’ herab
Klinischer Meilenstein ohne Kursschub: Aktie von Monte Rosa Therapeutics unter Druck
Biomea Fusion Aktie mit Kurssprung nach Abschluss der Rekrutierung für Diabetes-Studie
Monte Rosa Aktie fällt nach Start von Phase-2-Studie zu Prostatakrebs
ROUNDUP/Aktien New York: Chipwerte belasten Nasdaq kräftig - Dow leicht im Plus
Crinetics Pharmaceuticals Aktie erreicht Allzeithoch bei 84,8 USD
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.08 | +642.86% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0026 | +160.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.65 | +20.44% |
APRE Aprea Therapeutics, Inc. - Common Stock | 0.75 | +17.19% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.81 | +16.77% |
BCTXZ BriaCell Therapeutics Corp. - Warrant | 0.1201 | +14.38% |
CRDF Cardiff Oncology, Inc. - Common Stock | 1.00 | +13.64% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0045 | -50.00% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 7.84 | -26.87% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.09 | -18.17% |
ADXN Addex Therapeutics Ltd - American Depositary Shares | 4.14 | -16.19% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0928 | -15.48% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTXL BriaCell Therapeutics Corp. - Warrants | 0.9500 | -12.04% |